Study shows that the levels of the mRNA and protein of S100A4 are significantly higher in high-grade prostate cancer specimens compared with benign prostatic hyperplasia, prostatitis, and low-grade prostate cancer [125]. This evidence concerns the gene S100A4 and urogenital neoplasm.